Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474817 | SCV000556195 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-12-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002227164 | SCV002506144 | likely benign | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446860 | SCV002683280 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |